Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis

BACKGROUND: Renal cell carcinoma (RCC) accounts for 2% to 3% of all human malignancies and is the 9th most common malignancy in Western countries. Due to the development of surgical procedures and the use of novel drugs, survival has been significantly prolonged. However, current challenges include...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Baozhong, Zhang, Jiandong, Sun, Zejia, Cao, Peng, Zheng, Xiang, Gao, Zihao, Cao, Haoyuan, Zhang, Feilong, Wang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
7300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793379/
https://www.ncbi.nlm.nih.gov/pubmed/33429832
http://dx.doi.org/10.1097/MD.0000000000024257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793379/
https://www.ncbi.nlm.nih.gov/pubmed/33429832
http://dx.doi.org/10.1097/MD.0000000000024257

Ejemplares similares